Search clinical trials for: Atopic dermatitis, ASM981, pimecrolimus

Total 1469 results

Novartis

Completed

Extension Study of Pimecrolimus Cream in Pediatric Patients With Atopic Dermatitis

Atopic Dermatitis

Japan
Novartis

Completed

Extension Study to Assess Safety and Efficacy of Pimecrolimus in Adult Patients With Atopic Dermatitis

Atopic Dermatitis

Japan
Novartis

Completed

Reconstitution With Pimecrolimus Cream 1% of Steroid-damaged Skin in Adults With Atopic Dermatitis

Atopic Dermatitis

Germany
Novartis

Completed

Safety and Efficacy of Pimecrolimus Ophthalmic Suspension in Patients With Moderate to Severe Keratoconjunctivitis Sicca

Keratoconjunctivitis Sicca

United States
Sanofi

Recruiting

A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in Participants Aged 12 Years and Older With Moderate-to-severe AD Who Have Had an Inadequate Response to Prior Biologic Therapy or an Oral JAK Inhibitor (AQUA)

Dermatitis Atopic

Chile, United Kingdom, United States, Canada, Turkey, Israel, Korea, Republic of
MEDA PHARMA SPA, a Viatris company

Not yet recruiting

Observational Study to Evaluate Use of Elidel® in South and East Asian Pediatric Patients With Atopic Dermatitis. (Elidel-SEA)

Mild to Moderate Atopic Dermatitis
HK inno.N Corporation

Not yet recruiting

A Study to Evaluate the Safety, Tolerability and Pharmacokinetic Properties of IN-A002 Ointment in Healthy Adult Male Volunteers and Mild to Moderate Atopic Dermatitis Patients

Mild to Moderate Atopic Dermatitis
Bausch Health Americas, Inc.
Clinical Research Computing Unit (University of Pennsylvania)

Recruiting

10 Year Registry of Children (Ages 2-17 Years) With Eczema That Have Used Pimecrolimus (PEER)

Atopic Dermatitis

United States
Mylan Inc.
Medicine Meda Pharmaceutical Information Consultancy (Beijing) Co., Ltd.

Completed

Observational Study to Evaluate the Actual Use of Elidel® in Chinese Patients With Mild to Moderate Atopic Dermatitis

Atopic Dermatitis

China
Mylan Inc.
DPT Laboratories, Ltd.

Completed

Bioequivalence Study of Pimecrolimus Cream, 1% and Elidel® Cream, 1% in Mild to Moderate Atopic Dermatitis

Atopic Dermatitis

United States, Dominican Republic, Honduras
MEDA Pharma GmbH & Co. KG

Completed

5-Year Safety Study of Pimecrolimus Cream 1% in Infants 3 - 12 Months of Age With Mild to Moderate Atopic Dermatitis

Atopic Dermatitis

United States, Germany
Pfizer

Terminated

A Study of Crisaborole Ointment 2%; Crisaborole Vehicle; TCS and TCI in Subjects Aged ≥ 2 Years, With Mild-moderate AD

Atopic Dermatitis

United States, Poland, Germany, United Kingdom, Italy, Sweden, Switzerland
National Medical Research Center for Children's...

Completed

Prevention of Development of Transcutaneous Sensitization in Children With Atopic Dermatitis During Their First Year of Life

Atopic Dermatitis

Russian Federation
Actavis Inc.

Completed

Study of Equivalence of Generic Pimecrolimus Cream 1% and Elidel® 1% in Subjects With Mild to Moderate Atopic Dermatitis

Atopic Dermatitis

United States
LEO Pharma

Completed

LEO 29102 Cream in the Treatment of Atopic Dermatitis

Atopic Dermatitis

Canada, Finland, Germany
Glenmark Pharmaceuticals Ltd. India

Completed

Study of Generic Pimecrolimus Cream, 1% in the Treatment of Mild to Moderate Atopic Dermatitis

Atopic Dermatitis

United States
Novartis Pharmaceuticals

Completed

Open Label Study of Long Term Treatment of Pediatric Treatment of Atopic Dermatitis With Pimecrolimus Cream 1% Within a Usual Clinical Setting

Atopic Dermatitis

Venezuela, Mexico
Par Pharmaceutical, Inc.

Completed

Safety and Bioequivalence of Pimecrolimus Cream 1% and Elidel R in Treatment of Mild to Moderate Atopic Dermatitis

Atopic Dermatitis
LEO Pharma

Completed

A Clinical Trial to Compare Topical Agents in Adults With Mild to Moderate Atopic Dermatitis (AD)

Atopic Dermatitis

Canada, Israel
National Jewish Health

Completed

Effects of Pimecrolimus on Skin Biopsy Ex-plants From Patients With Atopic Dermatitis

Atopic Dermatitis

United States
Novartis Pharmaceuticals

Completed

Assessment of Pruritus Improvement With Pimecrolimus Treatment on the Areas Affected by Mild-to-moderate AD, in Patients 2- to 11- Year-old

Atopic Dermatitis

Spain
Novartis

Completed

Open-label Study to Investigate Systemic Exposure in Adult and Pediatric Atopic Dermatitis Patients Treated 8.5 Days With Pimecrolimus Cream 1% Under Occlusion

Atopic Dermatitis

Germany
Amorepacific Corporation

Completed

A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Atopic Dermatitis

Atopic Dermatitis
LEO Pharma

Completed

A Multi-Centre Clinical Trial to Evaluate a Left-Right Design in Adults With Mild to Moderate Atopic Dermatitis

Atopic Dermatitis

Germany
Bayer

Completed

A Clinical Study in Children and Adolescents With Mild to Moderate Atopic Dermatitis

Mild to Moderate Atopic Dermatitis

Germany
Astellas Pharma Inc

Completed

Comparison Study Between Protopic (Tacrolimus Ointment) and Elidel (Pimecrolimus Cream) in Treating Pediatric Patients With Atopic Dermatitis

Dermatitis, Atopic

United States
Astellas Pharma Inc

Completed

A Comparison Study Between Protopic (Tacrolimus) Ointment and Elidel (Pimecrolimus) Cream in Treating Subjects With Atopic Dermatitis

Dermatitis, Atopic

United States, Canada
Astellas Pharma Inc

Completed

Comparison Study Between Protopic (Tacrolimus Ointment) and Elidel (Pimecrolimus Cream) in Pediatric Patients With Mild Atopic Dermatitis

Dermatitis, Atopic

United States
Technische Universität Dresden

Completed

Comparison of Atrophogenic Effect of Hydrocortison 1% Cream and Pimecrolimus 1% Cream Assessed by Optical Coherence Tomography (OCT) and 20-MHz Ultrasound of Uninvolved Skin in Patients With Atopic Dermatitis (OCT-AD)

Atopic Dermatitis

Germany
University of California, San Diego
Novartis

Completed

Effect of Pimecrolimus Cream on Cathelicidin Levels in Subjects With Eczema

Atopic Dermatitis

United States
Frankel, Amylynne, M.D.
Onset Therapeutics, Inc

Completed

Bilateral Comparison Study of Elidel 1% and Hylatopic Plus Emollient Foam for the Treatment of Subjects With Atopic Dermatitis

Eczema | Atopic Dermatitis

United States
Novartis Pharmaceuticals

Terminated

Safety and Efficacy of Pimecrolimus Cream 1% in Atopic Disease Modification

Atopic Dermatitis

United States
Emer, Jason, M.D.
Ferndale Laboratories

Completed

Pimecrolimus Cream 1% (Elidel®) and Medicated Device Cream (EletoneTM) in the Treatment and Maintenance of Atopic Dermatitis.

Atopic Dermatitis

United States
Children's Hospital of Philadelphia
Novartis Pharmaceuticals

Completed

Combination Therapy for Atopic Dermatitis

Atopic Dermatitis

United States
University Hospital Muenster
Novartis Pharmaceuticals

Completed

Evaluation of the Antipruritic Effect of Elidel (Pimecrolimus) in Non-atopic Pruritic Disease (CASM981CDE21)

Prurigo Nodularis

Germany
Technische Universität Dresden

Completed

Standardized Time- and Score-oriented Treatment of Moderate and Severe Atopic Dermatitis

Moderate to Severe Atopic Dermatitis

Germany
University of Kiel
Deutsche Forschungsgemeinschaft, Bonn, Germany; Novartis Pharma GmbH, Nürnberg...

Completed

Pimecrolimus and Epidermal Barrier Function

Atopic Dermatitis

Germany
Children's Hospital of Michigan
Novartis Pharmaceuticals

Terminated

Study of Pimecrolimus Treatment for Atopic Dermatitis of African American Children

Atopic Dermatitis
Technische Universität Dresden

Completed

Elidel-Study: Elidel in Patients With Atopic Dermatitis

Atopic Dermatitis

Germany
Novartis

Completed

Comparison of Pimecrolimus Cream 1% Twice-Daily to Once-Daily Dosing in the Management of Atopic Dermatitis in Pediatric Subjects

Atopic Dermatitis

Switzerland
Novartis

Completed

A Quality of Life and Safety Study With Pimecrolimus Cream, 1% in Children (Age 2-12 Years) With Atopic Dermatitis

Atopic Eczema

South Africa
Novartis

Completed

Efficacy and Safety of Pimecrolimus Cream 1% in Patients ≥ 3 Months of Age With Mild or Moderate Atopic Dermatitis

Atopic Dermatitis

Philippines
Ceragenix Pharmaceuticals

Completed

Epiceram Versus Elidel for Treatment of Mild to Moderate Atopic Dermatitis

Atopic Dermatitis

United States
Novartis

Completed

Steroid-Sparing Effect With Pimecrolimus in Pediatric Patients With Atopic Dermatitis

Atopic Dermatitis

Germany
Novartis

Completed

Quality of Life Study in Adults With Facial Eczema

Atopic Dermatitis

United Kingdom
Novartis

Completed

Safety and Efficacy of Pimecrolimus Cream 1% in Mild to Moderate Head and Neck Atopic Dermatitis (AD) Patients

Atopic Dermatitis

Switzerland
Novartis

Completed

Efficacy and Safety of Pimecrolimus Cream 1% in Patients (2 to 11 Years Old) With Mild to Moderate Facial Atopic Dermatitis

Atopic Dermatitis

United States
Novartis

Completed

Pimecrolimus Cream 1% Plus Topical Corticosteroid in Patients (2-17 Years of Age) With Severe Atopic Dermatitis

Dermatitis, Atopic

United States
Novartis

Completed

Effects of Pimecrolimus Cream 1% on the Molecular and Cellular Profile of Adult Male Patients With Atopic Dermatitis

Atopic Dermatitis

United States
Novartis

Completed

Follow-Up Study of Patients Previously Treated With Pimecrolimus Tablets for Atopic Dermatitis

Atopic Dermatitis

3

Subscribe